Table 1.

Percentages of the body surface area of irradiated region in comparison with initial involvement of cutaneous T-cell lymphoma at enrollment and regimen of irradiation

Patient	Age/Race/Sex	Stage	On- study TBSA	BSA irradiated	Type of lesions	Cycle	Energy	Dose per fraction	No. of fractions
1	41/W/M	IIB	16%	2.5%	plaques	6-7	9 MeV	180 cGy	20
				2.0%	plaques	43-44	6 MeV	180 cGy	20
2	41/W/F	IVA2	91.5%	8.6%	papules	10	6 MeV	600 cGy	4
				9.7%	papules	11	6 MeV	400 cGy	6
				10.7%	plaques	12	6 MeV	400 cGy	8
3	61/W/F	IIB	0.8%a	0.3%	tumors	3	6 MeV	400 cGy	12
				0.1	tumors	4	6 MeV	400 cGy	4
				0.1	tumors	6	6 MeV	400 cGy	6
				0.01	tumor	12	6 MeV	400 cGy	2
4	34/AA/F	IVA2	82%	6%	plaques	10 - 11	6 MeV	180 cGy	10
5	42/W/M	IIB	36.5%b	2.9%	tumors	7	6 MeV	200 cGy	5
				2.0%	plaques	10	6 MeV	200 cGy	5

TBSA, Total Body Surface Area for patches and plaques only; BSA, Body Surface Area;

^aAll CTCL lesions were tumors.

^bPatient had tumors occupying additional 10% of TBSA